Business

Announcement on Voluntary Disclosure of Cooperation with Shanghai Skin Disease Hospital to Develop Class 1.1 New Traditional Chinese Medicine Compound Platycladus Orientalis Tincture for the Treatment of Hair Loss

Announcement on Voluntary Disclosure of Cooperation with Shanghai Skin Disease Hospital to Develop Class 1.1 New Traditional Chinese Medicine Compound Platycladus Orientalis Tincture for the Treatment of Hair Loss

articleShanghai Xiao Fang Pharmaceutical Co., Ltd. Class AJune 12, 20253/news/announcement-on-voluntary-disclosure-of-cooperation-with-shanghai-skin-disease-hospital-to-develop-class-11-new-traditional-chinese-medicine-compound-platycladus-orientalis-tincture-for-the-treatment-of-hair-loss
Announcement on Voluntary Disclosure of Cooperation with Shanghai Skin Disease Hospital to Develop Class 1.1 New Traditional Chinese Medicine Compound Platycladus Orientalis Tincture for the Treatment of Hair Loss

About this update from Shanghai Xiao Fang Pharmaceutical Co., Ltd. Class A

Announcement on Voluntary Disclosure of Cooperation with Shanghai Skin Disease Hospital to Develop Class 1.1 New Traditional Chinese Medicine Compound Platycladus Orientalis Tincture for the Treatment of Hair LossThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Xiao Fang Pharmaceutical Co., Ltd. Class A